Shenzhen Techdow Company Profile
What is the competitive landscape for SHENZHEN TECHDOW
SHENZHEN TECHDOW has five approved drugs.
Drugs and US Patents for Shenzhen Techdow
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shenzhen Techdow | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 202957-001 | Jun 12, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shenzhen Techdow | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 205660-002 | Mar 15, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shenzhen Techdow | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 205660-003 | Mar 15, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

